Medtech Insights

While the COVID-19 pandemic has had a negative impact on the European peripheral vascular device market in the short term, the dynamic nature of the PV market, the launch of novel premium-price…

Compared to other major orthopedic device markets, the Asia Pacific trauma device market has been somewhat less severely impacted by the COVID-19 pandemic given the urgent nature of many trauma…

In 2020, the procedure deferrals due to the COVID-19 pandemic severely impacted the global hernia repair device market. However, the overall market for hernia repair devices will exhibit …

The COVID-19 pandemic has negatively impacted the overall US foot and ankle orthopedic device market. Although the regional restrictions on elective procedures resulted in delays to foot and…

The European neurostimulation device market has been strongly impacted by the COVID-19 pandemic; however, following this impact, it will grow modestly, fueled by the ongoing product innovation…

Despite the impact of the ongoing COVID-19 pandemic, the market is expected to stabilize, following which overall ENT procedure volumes will grow only slightly in Europe through 2030, hampered…

Despite the negative impact of the COVID-19 pandemic in the short term, the European market will grow slightly through 2030, driven by an expanding CAD patient pool, an increasing prevalence…

The COVID-19 pandemic has negatively impacted the US biosurgical agent market due to the deferral or cancelation of elective and semielective procedures. Although the market is impacted in…

The COVID-19 global pandemic will have a significant impact on the Asia Pacific CRM device market in the short term, resulting in lost procedure volumes; however, following a period of recovery,…

While the COVID-19 pandemic had a negative, albeit relatively limited, impact on the European TEO device market in the short term, the market will grow modestly over the forecast period, driven by…

Despite the negative—albeit relatively limited—impact of the ongoing COVID-19 pandemic, the Asia Pacific interventional oncology device market will see strong growth through 2030 driven by…

Growing AF treatment volumes, driven by an expanding patient pool, rising awareness of ablation procedures, and improving access to health care, will fuel strong growth in the Asia Pacific EP …